OCLN and Parkinson disease: In mouse models of Parkinson’s disease and brain injury, sodium butyrate increased occludin and zonula occludens-1 (ZO-1) expression in the hippocampus and frontal cortex, supporting BBB function [75,76], while supplementation with 2% butyrate in G93A mice restored gut integrity and extended lifespan [77].